Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot

By CNBC   |   1 week ago
Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot

Moderna's mRNA-based flu vaccine showed stronger immune response in trials, paving the way for approval. The company plans to resubmit a combination flu and Covid jab for approval, aiming for both shots to be approved next year. The vaccine simplifies vaccination, reducing costs and improving patient uptake.

Read More

Did you find this insightful?